1-4 of 4
Theodore E. Warkentin
Close
Sort by
Journal Articles

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia

Jason B. Giles, Heidi E. Steiner, Jerome Rollin, Christian M. Shaffer, Yukihide Momozawa, Taisei Mushiroda, Chihiro Inai, Kathleen Selleng, Thomas Thiele, Claire Pouplard, Nancy M. Heddle, Michiaki Kubo, Elise C. Miller, Kiana L. Martinez, Elizabeth J. Phillips, Theodore E. Warkentin, Yves Gruel, Andreas Greinacher, Dan M. Roden, Jason H. Karnes
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4137–4146.
https://doi.org/10.1182/bloodadvances.2022007673
Published: 2022
Includes: Supplemental data
Journal Articles

Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses

Rebecca L. Morgan, Vahid Ashoorion, Adam Cuker, Housne Begum, Stephanie Ross, Nina Martinez, Beng H. Chong, Lori A. Linkins, Theodore E. Warkentin, Wojtek Wiercioch, Robby Nieuwlaat, Holger Schünemann, Nancy Santesso
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5184–5193.
https://doi.org/10.1182/bloodadvances.2020002963
Published: 2020
Includes: Supplemental data
Journal Articles

A practical approach to evaluating postoperative thrombocytopenia

Clinical Trials & Observations
Leslie Skeith, Lisa Baumann Kreuziger, Mark A. Crowther, Theodore E. Warkentin
Journal: Blood Advances
Blood Adv (2020) 4 (4): 776–783.
https://doi.org/10.1182/bloodadvances.2019001414
Published: 2020
Journal Articles

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia

Adam Cuker, Gowthami M. Arepally, Beng H. Chong, Douglas B. Cines, Andreas Greinacher, Yves Gruel, Lori A. Linkins, Stephen B. Rodner, Sixten Selleng, Theodore E. Warkentin, Ashleigh Wex, Reem A. Mustafa, Rebecca L. Morgan, Nancy Santesso
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3360–3392.
https://doi.org/10.1182/bloodadvances.2018024489
Published: 2018
Includes: Supplemental data